Jump to navigation
22-year-old female patient who developed an acute polymorphic psychotic episode 3 days after receiving a booster vaccination...
39-year-old man with a recurrent episode of gouty arthritis presented prednisolone-resistant polyarthritis with high level...
51-year-old man complained of hematemesis for 5 hours and syncope once.
39-year-old diabetic female with Behcet's disease presented with acute inferior wall myocardial infarction and underwent...
72-year-old woman presented 9 months ago with skin rash on her bilateral forearms, which was followed by intermittent high...
63-year-old male patient suffered from MPCNSLs but without typical clinical manifestations. The findings of the imaging examination...
43-year-old male patient who presented with recurrent otitis media and mixed hearing loss that is the 12th case of IgG4-RD...
43-year-old female presented in the emergency department of the hospital with SE. Her previous medical and family history...
19 year-old young man who is the first adult-onset PFAPA patient in Iran and was accompanied by splenomegaly. Since March...
56-year-old woman with systemic lupus erythematosus who was diagnosed with an organizing pneumonia and showed a poor response...
PeerVoice invites you to explore the education and resources on this site that provides a comprehensive approach to managing your patients
User-friendly learning modules available in short and accessible formats.
Insights and developments from leading experts.
Continuously updated news and conference coverage.
Helpful resources for your practice and patients.
Canakinumab for the Treatment of Auto-Inflammatory Recurrent Fever Syndromes
De Benedetti F et al. N Engl J Med. 2018;378:1908-1919
Treating Juvenile Idiopathic Arthritis to Target: Recommendations of an International Task Force
Ravelli A et al. Ann Rheum Dis. 2018;77:819-828
Validation of the Auto-Inflammatory Diseases Activity Index (AIDAI) for Hereditary Recurrent Fever Syndromes
Piram M et al. Ann Rheum Dis. 2014;73:2168-2173
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Goldbach-Mansky R et al. N Engl J Med. 2006;355:581-592
Current Understanding of the Pathophysiology of Systemic Juvenile Idiopathic Arthritis (sJIA) and Target-Directed Therapeutic Approaches
Bruck N et al. Clin Immunol. 2015;159:72-83
This activity is supported by funding from Novartis Pharma AG.